Animal-Related
(D20)
990 on File
SARATOGA THERAPEUTIC EQUESTRIAN PROGRAM INC
Financial strength (30%)
70/100
Reliability (20%)
55/100
Effectiveness (25%)
75/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$193K
Total Revenue
$185K
Total Expenses
$90K
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
99.8%
Fundraising Efficiency
N/A
Operating Reserve
5.84x
Liability-to-Asset
20.3%
Revenue Diversification
74.6%
Compared with Peers
FY 2023
Compared with 6,188 similar organizations
(United States, Animal-Related, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
99.8% | 91.9% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
0.2% | 6.3% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.8 mo | 9.6 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
20.3% | 0.5% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
74.6% | 89.2% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
33.1% | 6.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.1% | 10.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
4.1% | 1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $193K | $185K | $90K | 99.8% | 2 |
| 2022 | $145K | $178K | $82K | 99.8% | 2 |
| 2021 | $129K | $126K | N/A | — | 2 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.